Clinicopathological changes in calves with respiratory diseases after treatment with essential volatile oil and other drugs

Document Type : Original Article

Authors

1 Clinical Pathology Dep. Fac. Vet.Med. Benha Univ.

2 Clinical Pathology Dep. Fac. Vet.Med. Benha Univ.,

3 Animal Health Research Institute (Zagazig provincial Lab.)

Abstract

This study was performed on fifteen newly born calves, 3-5-month-old with clinical signs of bronchopneumonia in addition to five clinically healthy calves which considered as control group. After bacterial isolation and identification of the causative microorganisms, fifteen calves from which was found infected with Pasteurella spp. and Haemophilus spp. The diseased calves were divided randomly into three equal groups which respectively, treated with: Gp.1: were treated dose of draxxin (2.5 mg/kg body weight) by s/c injection in the neck; Gp.2: were received Draxxin and Meloxicam (single I/M injection of 0.5 mg/kg b.wt.), while Gp.3: were received draxxin (single s/c injection of 20 mg/kg b.wt.) +Symopro on drinking water (150-300 ml/1000 L for 5 days). Blood and serum samples were collected from all calves just before treatment, 3 and 10 days post treatment. pH, PO2 and SO2 results recorded significant increase in all treated groups. Meanwhile, PCO2, tCO2 and HCO3 results showed significant decrease in all treated groups compared with diseased group before treatment. Haptoglobin and fibrinogen results showed significant decrease in all treated groups compared with diseased group before treatment. GSH-PX results revealed significant increase. Meanwhile, MDA results showed significant decrease in all treated groups which comparatively with those before treatment. There was significant increase in cellular immunity (phagocytic index and phagocytic%) in treated group with draxxin plus sympro when compared with diseased group before treatment.

Keywords

Benha Veterinary Medical Journal
Volume 33, Issue 2
December 2017
Pages 237-247

Files

Share

How to cite

Statistics